单位：[1]Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Taipei, Taiwan[2]Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[3]Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China[4]Nanfang Hosp, Guangzhou, Guangdong, Peoples R China[5]Third Mil Med Univ, Xi Nan Hosp, Chongqing, Peoples R China[6]1 Hosp, Changchun, Peoples R China[7]Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China[8]Ruijin Hosp, Shanghai, Peoples R China[9]Nova Pharmaceut Corp, E Hanover, NJ USA[10]Novartis Pharma AG, Basel, Switzerland
Chen Y. -C.,Hsu C. -W,Liaw Y. -F,et al.EFFICACY OF 3 YEARS OF TELBIVUDINE TREATMENT FOR PATIENTS WITH GENOTYPE B/C CHRONIC HEPATITIS B (CHB)[J].JOURNAL of HEPATOLOGY.2009,50:S329-S329.doi:10.1016/S0168-8278(09)60908-9.
APA：
Chen, Y. -C.,Hsu, C. -W,Liaw, Y. -F,Jia, J.,Leung, N....&Lopez, P..(2009).EFFICACY OF 3 YEARS OF TELBIVUDINE TREATMENT FOR PATIENTS WITH GENOTYPE B/C CHRONIC HEPATITIS B (CHB).JOURNAL of HEPATOLOGY,50,
MLA：
Chen, Y. -C.,et al."EFFICACY OF 3 YEARS OF TELBIVUDINE TREATMENT FOR PATIENTS WITH GENOTYPE B/C CHRONIC HEPATITIS B (CHB)".JOURNAL of HEPATOLOGY 50.(2009):S329-S329
医学